David Uehling
Impact in
- Molecular Biology top 5%
- Signaling Pathways in Disease
- Melanoma and MAPK Pathways
- Cancer therapeutics and mechanisms
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Receptor Mechanisms and Signaling 6
- Melanoma and MAPK Pathways 5
- Cancer therapeutics and mechanisms 4
-
- Asymmetric Synthesis and Catalysis 5
- Synthesis and biological activity 4
- Co-authors
- Matthew W. Harding (1 shared paper)Stuart L. Schreiber (1 shared paper)Andrzej Gałat (1 shared paper)Clayton H. Heathcock (2 shared papers)Stuart L. Schreiber (3 shared papers)Rima Al‐awar (16 shared papers)Tarek Sammakia (2 shared papers)Masashi Nakatsuka (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Medicinal Chemistry (7 papers)Journal of Biological Chemistry (3 papers)The Journal of Organic Chemistry (3 papers)Journal of the American Chemical Society (2 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
David Uehling
46 papers receiving 3.1k citations
David Uehling's Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 2.3k
- Oncology 800
- Toxicology 96
- Organic Chemistry 756
- Immunology 411
Countries citing papers authored by David Uehling
This map shows the geographic impact of David Uehling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Uehling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Uehling more than expected).
Fields of papers citing papers by David Uehling
This network shows the impact of papers produced by David Uehling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Uehling. The network helps show where David Uehling may publish in the future.
Co-authors
The 25 scholars most cited alongside David Uehling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase Hit paper breakdown → | 1989 | 1154 |
| 2 | 1990 | 193 | |
| 3 | 2013 | 175 | |
| 4 | 2016 | 169 | |
| 5 | 2013 | 163 | |
| 6 | 1995 | 122 | |
| 7 | 2014 | 84 | |
| 8 | 1985 | 79 | |
| 9 | 2011 | 77 | |
| 10 | 2011 | 76 | |
| 11 | 2008 | 72 | |
| 12 | 2012 | 67 | |
| 13 | 2001 | 48 | |
| 14 | 1986 | 47 | |
| 15 | 1995 | 46 | |
| 16 | 2015 | 46 | |
| 17 | 2009 | 45 | |
| 18 | 2016 | 42 | |
| 19 | 2013 | 35 | |
| 20 | 2009 | 33 |
About David Uehling
David Uehling is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 3.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Melanoma and MAPK Pathways (5 papers), Asymmetric Synthesis and Catalysis (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer-related Molecular Pathways (4 papers), Glioma Diagnosis and Treatment (4 papers), Cancer therapeutics and mechanisms (4 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Molecular Biology (2.3k citations), Oncology (800 citations), Toxicology (96 citations), Organic Chemistry (756 citations) and Immunology (411 citations). David Uehling has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Matthew W. Harding, Stuart L. Schreiber, Andrzej Gałat, Clayton H. Heathcock, Stuart L. Schreiber, Rima Al‐awar, Tarek Sammakia, Masashi Nakatsuka, John A. Ragan and David B. Smith. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, The Journal of Organic Chemistry and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.